NovoCure Ltd. Hits Day High with 27.68% Surge in Stock Price

NovoCure Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced significant activity today, gaining 27.68% as of February 25, 2026. The stock reached an intraday high of USD 15.46, marking a notable milestone in its trading performance. In terms of performance metrics, NovoCure's one-day gain of 27.68% stands in stark contrast to the S&P 500's modest increase of 0.69%. Over the past week, NovoCure has shown a robust performance with a 31.49% rise, while its one-month performance is up by 11.45%. However, the stock has faced challenges over the longer term, with a one-year decline of 28.62% compared to the S&P 500's gain of 12.95%. Despite its recent gains, NovoCure's long-term performance remains concerning, with a three-year decline of 80.53% and a five-year drop of 89.93%. The company currently holds a market capitalization of USD 1,272 million and has high institutional holdings at 100%, indicating strong backing from institutional investors.